Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A Yahoo Finance piece argues the answer to whether TSLA is set up for a rebound depends less on an upcoming earnings event and more on investors’ long-term view of Tesla’s strategy.
THE APEX TIMES
THE APEX TIMES
A prominent Tesla bull, Gary Black, said SpaceX could not afford Tesla and argued the company structure would still require fiduciary discipline even if Elon Musk controls Tesla’s voting outcome.
THE APEX TIMES
The streaming company’s guidance for the current quarter landed below Wall Street expectations, triggering a sharp selloff in after-hours trading.
THE APEX TIMES
A wave of online complaints about the strictness of safeguards in Anthropic’s latest AI model spilled into market chatter, with Microsoft leadership weighing in and investors reacting to the broader debate over how tightly frontier AI should be constrained.
THE APEX TIMES
Uber said its proposed acquisition approach to Delivery Hero is aimed at deepening its cross-platform mobility and delivery footprint, with management pointing to reach and cost benefits it expects if a deal is completed.
THE APEX TIMES
A recent look at CVS Health’s stock performance points to a potential mismatch between strong share momentum and what investors appear to be pricing in, with attention focused on the company’s ongoing exposure to antitrust and pricing scrutiny tied to insulin.
THE APEX TIMES
A July 17 market commentary argues that clues emerging across Alphabet’s AI ecosystem, SpaceX’s scaling efforts, and SK Hynix’s memory position point to improving momentum, even if specifics are not tied to a single catalyst.
THE APEX TIMES
The streaming company reported revenue at a new high level, yet its next-quarter outlook landed below what many investors were expecting, weakening sentiment around the shares.
THE APEX TIMES
Visa has posted strong gains over the past three years, yet a fresh valuation screen suggests the stock may be trading below a model-based estimate of fair value even as it remains priced above what earnings alone would imply.
